Oxidative stress markers regulating the healing of foot ulcers in patients with type 2 diabetes

Wounds

Volumn 21, Issue 10, 2009, Pages 273-279

  Vairamon, Shiny John ^a   Babu, Mary ^b   Viswanathan, Vijay ^c  

^a STELLA MARIS COLLEGE   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^c Diabetes Research Centre Tamil Nadu   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73849140191     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318(20):1315-1321.
2. Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders. A clinical practice guideline. For the American College of Foot and Ankle Surgeons and the American College of Foot and Ankle Orthopedics and Medicine. J Foot Ankle Surg. 2000;(Suppl):1-60.
3. Vijay V, Narasimham DV, Seena R, Snehalatha C, Ramachandran A. Clinical profile of diabetic foot infections in south India-a retrospective study. Diabet Med. 2000;17(3):215-218.
4. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989;264(35):21340-21345.
5. Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med. 1996;13(8):715-719.
6. Szaleczky E, Prechl J, Fehér J, Somogyi A. Alteration in enzymatic antioxidant defence in diabetes mellitus-a rational approach. Postgrad Med J. 1999;75(879):13-17.
7. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract. 2001;53(1):33-39.
8. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17(6):557-560.
9. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care. 1998;21(12):2161-2177.
10. Wagner WF Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64-122.
11. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
12. Yagi K. Assay for blood plasma or serum. Methods Enzymol. 1984;105:328-331.
13. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170-3175.
14. Caliborne AL. Decrease in absorbance at 240 nm due to decomposition of H2O2. In: Greenwald RA, ed. Hand Book of Methods for Oxygen Radical Research. Boca Raton, FL: CRC press; 1985:283-284.
15. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179(73):588-590.
16. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130- 7139.
17. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond). 1993;84(4):407-412.
18. Young MJ, Adams JE, Anderson GF, Boulton AJ, Cavanagh PR. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia. 1993;36(7):615-621.
19. Edmonds ME. The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab. 1986;15(4):889-916.
20. Ramachandran A. Specific problems of the diabetic foot in developing countries. Diabetes Metab Res Rev. 2004;(20 Suppl 1):S19-S22.
21. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant. 1998;13(11):2829-2832.
22. Kotake M, Shinohara R, Kato K, et al. Reduction of activity, but no decrease in concentration, of erythrocyte Cu, Zn-superoxide dismutase by hyperglycaemia in diabetic patients. Diabet Med. 1998;15(8):668-671.
23. Sekeroglu MR, Sahin H, Dülger H, Algün E. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem. 2000;33(8):669-674.
24. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond). 1996;90(4):255-260.
25. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 1988;37(6):832-837.
26. Maxwell SR, Thomason H, Sandler D, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997;27(6):484-490.